{"id":564542,"date":"2026-03-27T15:00:10","date_gmt":"2026-03-27T15:00:10","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/564542\/"},"modified":"2026-03-27T15:00:10","modified_gmt":"2026-03-27T15:00:10","slug":"how-ai-is-changing-alzheimers-and-dementia-care-health","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/564542\/","title":{"rendered":"How AI is changing Alzheimer\u2019s and dementia care | Health"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.newsbeep.com\/ca\/wp-content\/uploads\/2026\/03\/1774623610_112_pixel.gif\" alt=\"\" height=\"1\" width=\"1\" style=\"position: absolute; top: 0; left: 0;\"\/><\/p>\n<p>How AI is changing Alzheimer\u2019s and dementia care<\/p>\n<p>For the 11 million Americans caring for a loved one with dementia, the journey is rarely about \u201cbig news.\u201d Instead, it is defined by the long, difficult wait between doctor appointments and the search for answers that often come too late.<\/p>\n<p>When we discuss the \u201cnext generation\u201d of Alzheimer\u2019s and dementia care, the conversation usually focuses on a new pill or a laboratory breakthrough. However, the true challenge of the 2026 healthcare landscape is not just finding a treatment, but delivering it as well.<\/p>\n<p>From the initial diagnosis to the long-term monitoring of a patient\u2019s safety, the path to care is currently blocked by massive bottlenecks, specialist shortages, and manual paperwork.<\/p>\n<p>Artificial intelligence is uniquely suited to solve these specific systemic hurdles. While biology moves slowly, AI can process data at a scale that human systems cannot. By automating the \u201cinvisible infrastructure\u201d of dementia care, including early risk detection, high-speed clinical trial matching, and the monitoring of complex drug side effects, AI is changing Alzheimer\u2019s and dementia care.<\/p>\n<p>The following tools and updates have been compiled by <a href=\"https:\/\/kivo.io\/dms\" rel=\"nofollow noopener\" target=\"_blank\">Kivo<\/a>, a document, content, and process management platform designed for modern pharma teams.<\/p>\n<p>1. Finding the Early Warning Signs<\/p>\n<p>One of the biggest problems with treating Alzheimer\u2019s is timing. New drugs work best in the very early stages of the disease. Unfortunately, most families don\u2019t get help until memory loss is severe and the brain has already been damaged.<\/p>\n<p>AI is changing this by spotting \u201cwhispers\u201d that a human doctor might miss.<\/p>\n<p>Example No. 1: The Eye as a Window<\/p>\n<p>Researchers at the National University of Singapore created RetiPhenoAge, an AI tool that looks at photos of the eye. <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40042460\/\" rel=\"nofollow noopener\" target=\"_blank\">Their study found<\/a> that people with a \u201chigher retinal age\u201d have a 25%-40% higher risk of cognitive decline.<\/p>\n<p>Example No. 2: Listening to Speech<\/p>\n<p>A <a href=\"https:\/\/www.nia.nih.gov\/news\/ai-speech-analysis-predicted-progression-cognitive-impairment-alzheimers-over-78-accuracy\" rel=\"nofollow noopener\" target=\"_blank\">2024 study funded by the National Institute on Aging (NIA)<\/a> showed that AI can listen to how a person talks and predict Alzheimer\u2019s with 78.2% accuracy, up to six years before a medical diagnosis.<\/p>\n<p>By using AI to check eye scans or speech patterns during a regular check-up, doctors can find at-risk patients years earlier than before.<\/p>\n<p>2. Solving the Clinical Trial Bottleneck<\/p>\n<p>It typically takes over 10 years for a new drug to go from a lab to a pharmacy. One of the biggest bottlenecks in this process is finding an adequate number of volunteers to begin trials. In fact, 85% of clinical trials are delayed due to being unable to find enough volunteers.<\/p>\n<p>This bottleneck is especially challenging for Alzheimer\u2019s researchers, as a very specific type of patient is required: someone who is in the early stages of the condition but hasn&#8217;t yet reached full dementia.<\/p>\n<p>AI is now facilitating this process like a high-speed matchmaker. Tools like <a href=\"https:\/\/www.ncbi.nlm.nih.gov\/research\/trialgpt\/\" rel=\"nofollow noopener\" target=\"_blank\">TrialGPT<\/a>, which the National Institutes of Health (NIH) highlighted in late 2024, are changing the game for volunteer sourcing and reducing this massive bottleneck.<\/p>\n<p>TrialGPT matches patients to the right trials with 87.3% accuracy and does it 40% faster than humans.<\/p>\n<p>For someone caring for a parent, this increase in speed and convenience can make a huge difference. Instead of searching through confusing websites, AI can scan a patient\u2019s medical records and find a matching trial in seconds.<\/p>\n<p>3. Bridging the \u2018Neurology Desert\u2019 Gaps<\/p>\n<p><a href=\"https:\/\/kivo.io\/news\/the-best-worst-us-states-for-accessing-novel-treatment-trials\" rel=\"nofollow noopener\" target=\"_blank\">Where you live often decides what kind of care<\/a> and access you receive.<\/p>\n<p>The American Academy of Neurology (AAN) <a href=\"https:\/\/www.researchgate.net\/publication\/351273460_A_Shortage_of_Neurologists_We_Must_Act_Now_A_Report_From_the_AAN_2019_Transforming_Leaders_Program\" rel=\"nofollow noopener\" target=\"_blank\">warns that the U.S. will have a 19% shortage of neurologists<\/a> by 2025. This creates \u201cneurology deserts,\u201d where families might have to drive four hours for an appointment or wait six months to see a specialist.<\/p>\n<p>AI helps bridge this gap but making it easier for top specialists at big hospitals to support local doctors in small towns. Instead of a rural patient needing to fly to a big city to see a specialist on the chance they might be a fit, <a href=\"https:\/\/www.michiganmedicine.org\/health-lab\/ai-model-can-read-and-diagnose-brain-mri-seconds\" rel=\"nofollow noopener\" target=\"_blank\">AI can pre-read a patient\u2019s brain scans<\/a> and send a \u201cpriority report\u201d to specialists anywhere the internet can reach.<\/p>\n<p>This allows a few experts to help a far greater number of people. And for families in rural areas, this tech can be a life-changing and even life-saving bridge.<\/p>\n<p>The Cost of Doing Nothing<\/p>\n<p>The need for AI is clear when you look at the stress on American families. The <a href=\"https:\/\/www.alz.org\/alzheimers-dementia\/facts-figures\" rel=\"nofollow noopener\" target=\"_blank\">Alzheimer\u2019s Association 2024 Facts and Figures<\/a> report shows the true cost:<\/p>\n<p>Unpaid care for dementia in the U.S. is worth about $413.5 billion a year.About 57% of caregivers had to change their work hours, and 16% had to quit or take a leave of absence to stay home with a loved one.Caregivers for dementia patients are twice as likely to have emotional and physical health problems.<\/p>\n<p>AI helps shorten that stressful time when a family knows something is wrong but can&#8217;t get answers about how to care for their loved ones and get them the professional help they need. Getting a diagnosis faster also means families can plan better and save money.<\/p>\n<p>More Than Just a Headline<\/p>\n<p>As 2026 moves along, Alzheimer&#8217;s is becoming a manageable condition rather than a \u201cdead end.\u201d AI will never replace the love of a caregiver or the skill of a doctor. But it can remove the friction that makes their lives so hard.<\/p>\n<p>The \u201cmiracle drug\u201d might get the headlines, but AI is the engine that makes existing drugs work for real people. For the next generation, AI means more time, more memories, and a healthcare system that finally moves as fast as the disease itself.<\/p>\n<p><a href=\"https:\/\/kivo.io\/news\/how-ai-is-changing-alzheimers-and-dementia-care\" rel=\"nofollow noopener\" target=\"_blank\">This story<\/a> was produced by <a href=\"https:\/\/kivo.io\" rel=\"nofollow noopener\" target=\"_blank\">Kivo<\/a> and reviewed and distributed by <a href=\"https:\/\/hubs.la\/Q03klgSR0\" rel=\"nofollow noopener\" target=\"_blank\">Stacker<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"How AI is changing Alzheimer\u2019s and dementia care For the 11 million Americans caring for a loved one&hellip;\n","protected":false},"author":2,"featured_media":564543,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[10],"tags":[32704,49,48,10237,84,16164,209180],"class_list":["post-564542","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-alzheimer","tag-ca","tag-canada","tag-dementia","tag-health","tag-medical-care","tag-thestacker"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/564542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=564542"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/564542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/564543"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=564542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=564542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=564542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}